SANTA CLARA, Calif.--(BUSINESS WIRE)--Iris BioTechnologies Inc. (OTCBB:IRSB), a life sciences company focused on providing patients, doctors, and clinicians with improved methods of identifying effective treatment solutions, and recipient of the Frost and Sullivan 2008 Technology Innovation Award in Pharmacogenomics, today announced two new Canadian patents. This brings the company’s total patent portfolio to four Canadian patents, four U.S. patents, and numerous other patents in the European Union, Asia, Australia and New Zealand.
